-
An FDA warning said the several of Bimbo Bakeries' products are “misbranded” because the labels list sesame or tree nuts even though those ingredients aren't in the foods.
-
A memo notes the new mRNA shot doesn't target the current dominant variant. A USF epidemiologist says it will still be effective but suggests first deciding whether you need the booster.
-
Upside Foods filed a lawsuit challenging the constitutionality of the law and requested a preliminary injunction.
-
The FDA considers plants that have gone more than five years without an inspection to be a significant risk. Officials say the work has been hampered by difficulties recruiting and retaining inspectors.
-
Of the 6 million prescriptions written for EpiPen auto-injectors each year, more than 40% are never filled, USF allergist Dr. Thomas Casale told an FDA advisory panel last year.
-
The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.
-
The story of MitraClip, a device Dr. Oz helped invent to treat faulty heart valves, is a cautionary tale about the science, business and regulation of medical technology.
-
A flood of litigation — with plaintiffs like small businesses, drugmakers, and hospitals challenging regulations — could leave the country with a patchwork of disparate health regulations.
-
The decision lends credibility to vaping companies’ claim that their products can help blunt the toll of smoking. Meantime, parents and anti-tobacco groups say the FDA has again “failed American families.”
-
The high court threw out a challenge to the FDA's rules on the abortion drug. A recently enacted Florida law permits use of the pill up to six weeks of gestation, but the medication must be taken in front of a doctor.